Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress

Pediatric Diabetes

Volumn 9, Issue 2, 2008, Pages 104-109

  Shamir, Raanan ^a,b   Kassis, Haifa ^a,b   Kaplan, Marielle ^b   Naveh, Tova ^a,b   Shehadeh, Naim ^a,b  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MALE; METABOLIC REGULATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISRAEL; LIPIDS; MALE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 42449155048     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00313.x     Document Type: Article

References (43)

1. National Cholesterol Education Program Coordinating Committee. Report of the Expert Panel on Blood Cholesterol in Children and Adolescents. Bethesda, MD: National Heart, Lung and Blood Institute, 1991. NIH Publication No. 91-2732.
2. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG. Genetic analysis of 500 survivors of acute MI. J Clin Invest 1973: 52: 1533-1543.
3. Desjeux JF. Monogenic disorders that cause LDL cholesterol to accumulate in plasma. J Pediatr Gastroenterol Nutr 2001: 33: 119-121.
4. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 2003: 26: 2194-2197.
5. Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients. Circulation 2006: 114: 2710-2738.
6. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III): Full Report. Bethesda, MD: National Institute of Health, 2001. NIH publication No. 01-3670.
7. The Diabetes Control and Complications Trial (DCCT) research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol 1995: 75: 894-903.
8. Lawson ML, Gerstein HC, Tsui E, Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care 1999: 22(Suppl. 2): B35-B39.
9. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: The SEARCH for diabetes in youth study. Diabetes Care 2006: 29: 1891-1896.
10. al Muhtaseb N, al Yousuf A, Bajaj JS. Apolipoprotein A-I, A-II, B, C-II, and C-III in children with insulin-dependent diabetes mellitus. Pediatrics 1992: 89: 936-941.
11. Bustos P, Radojkovic C, Ulloa N et al. Lipoprotein composition in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2005: 18: 257-264.
12. Azad K, Parkin JM, Court S, Laker MF, Alberti KG. Circulating lipids and glycaemic control in insulin dependent diabetic children. Arch Dis Child 1994: 71: 108-113.
13. Ladeia AM, Adan L, Couto-Silva AC, Hiltner A, Guimaraes AC. Lipid profile correlates with glycemic control in young patients with type 1 diabetes mellitus. Prev Cardiol 2006: 9: 82-88.
14. Gunczler P, Lanes R, Soros A et al. Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes. J Pediatr 2006: 149: 320-323.
15. Kershnar AK, Daniels SR, Imperatore G et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study. J Pediatr 2006: 149: 314-319.
16. Shamir R, Fisher EA. Dietary therapy for children with hypercholesterolemia. Am Fam Physician 2000: 61: 675-686.
17. Shamir R, Lerner A, Fisher EA. Hypercholesterolemia in children. Isr Med Assoc J 2000: 2: 767-771.
18. Gidding SS, Dennison BA, Birch LL et al. Dietary recommendations for children and adolescents: A guide for practitioners; consensus statement from the American Heart Association. Circulation 2005: 112: 2061-2075.
19. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996: 19: 257-267.
20. Maritim A, Sanders R, Watkins J. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003: 17: 24-38.
21. Erciyas F, Taneli F, Arslan B, Uslu Y. Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 2004: 35: 134-140.
22. American Diabetes Association. Nutrition recommendations and interventions for diabetes-2006. A position statement of the American Diabetes Association. Diabetes Care 2006: 29: 2140-2157.
23. American Diabetes Association Position Statement. Tests of glycemia in diabetes. Diabetes Care 2004: 27(Suppl. 1): S91-S93. (available from http://www.ngsp.org).
24. Shamir R, Shehadeh N, Rosenblat M et al. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient (E °) mice. Arterioscler Thromb Vasc Biol 2002: 23: 104-110.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
26. Sugiuchi H, Uji Y, Okabe H et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 1995: 41: 717-723.
27. Burtis C, Ashward E. Lipids, lipoproteins and apolipoproteins. In: Burtis C, Ashward E, eds. Tietz Textbook of Clinical Chemistry. Philadelphia, PA: W.B. Saunders, 1994: 1019-1024.
28. Shamir R, Johnson WJ, Morlock-Fitzpatrick K, Zolfaghari RR. Pancreatic carboxyl lipase: A circulating enzyme that modifies normal and oxidized lipoproteins in vitro. J Clin Invest 1996: 7: 1696-1704.
29. Strobl W, Widhalm K, Schober E, Frisch H, Pollak A, Westphal G. Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA 1. Acta Paediatr Scand 1985: 74: 966-971.
30. Simon A, Chironi G, Gariepy J, Del Pino M, Levenson J. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis 2005: 179: 339-344.
31. Jiang R, Schulze MB, Li T et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004: 27: 1991-1997.
32. Ewald U, Tuvemo T, Vessby B, Walinder O. Serum apolipoproteins A-I, A-II and B in diabetic children and matched healthy controls. Acta Paediatr Scand 1982: 71: 15-18.
33. Knopp RH, Van Allen MI, Mcneely M et al. Effect of insulin-dependent diabetes on plasma lipoproteins in diabetic pregnancy. J Reprod Med 1993: 38: 703-710.
34. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991: 88: 1785-1792.
35. Heinecke JW. Lipoprotein oxidation in cardiovascular disease: Chief culprit or innocent bystander? J Exp Med 2006: 203: 813-816.
36. Griesmacher A, Kindhauser M, Andert S et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995: 98: 469-475.
37. Hunt JV, Bottoms MA, Clare K, Skamarauskas JT, Mitchnson MJ. Glucose oxidation and low density lipoprotein induced macrophage ceroid accumulation: Possible implications for diabetic atherosclerosis. Biochem J 1994: 300: 243-249.
38. Hunt JV, Smith CC, Wolff SP. Autooxidative glycosylation and possible involvement of peroxidase and free radicals in LDL modification by glucose. Diabetes 1990: 39: 1420-1424.
39. Wittenstein B, Klein M, Finckh B, Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 2002: 33: 103-110.
40. Jakus V, Bauerova K, Michalkova D, Carsky J. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Bratisl Lek Listy 2000: 101: 484-489.
41. Varvarovska J, Racek J, Stetina R et al. Aspects of oxidative stress in children with type 1 diabetes mellitus. Biomed Pharmacother 2004: 58: 539-545.
42. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A. Insulin infusion in acute illness. J Clin Invest 2005: 115: 2069-2072.
43. Hayek T, Hussein K, Aviram M et al. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose. Atherosclerosis 2005: 183: 25-33.